产品封面图

Anti-phospho-Eph receptor A2+A

3+A4 (Tyr588 + Tyr596)抗体
收藏
  • 询价
  • 西格
  • XGK1345
  • 进口、国产
  • 2025年07月15日
  • WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
  • 详见说明书
  • 详见说明书
avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      上海西格

    • 库存

      32

    • 靶点

      详见说明书

    • 级别

      详见说明书

    • 目录编号

      详见说明书

    • 克隆性

      多克隆

    • 抗原来源

      Rabbit

    • 保质期

      详见说明书

    • 抗体英文名

      Anti-phospho-Eph receptor A2+A3+A4 (Tyr588 + Tyr596)

    • 抗体名

      磷酸化内皮细胞受体蛋白酪氨酸激酶A2+A3+A4抗体

    • 标记物

      详见说明书

    • 宿主

      详见说明书

    • 适应物种

      详见说明书

    • 免疫原

      KLH conjugated synthesised phosphopeptide derived from human Eph receptor A2 around the phosphorylation site of Tyr588 + Tyr596

    • 亚型

      IgG

    • 形态

      详见说明书

    • 应用范围

      WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

    • 浓度

      1mg/1ml 

    • 保存条件

      详见说明书

    • 规格

      0.1ml/100μg  0.2ml/200μg  

    产品细节图片1
    产品名称 磷酸化内皮细胞受体蛋白酪氨酸激酶A2+A3+A4抗体
    英文名称 Anti-phospho-Eph receptor A2+A3+A4 (Tyr588 + Tyr596)抗体
    货号 XGK1345
    英文名称  Anti-phospho-Eph receptor A2+A3+A4 (Tyr588 + Tyr596)
    中文名称  磷酸化内皮细胞受体蛋白酪氨酸激酶A2+A3+A4抗体 
    别    名  Eph receptor A2+A3+A4(phospho Y588 + Y596) ECK; EPH Receptor A2; EPH Receptor A3; EPH Receptor A4; EPHA2; EPHA3; EPHA4; Ephrin type A receptor 2; Ephrin type A receptor 3; Ephrin type A receptor 4; Epithelial cell kinase; ETK; ETK1; HEK; HEK4; HEK8; Receptor protein tyrosine kinase HEK8; SEK; TYRO4; Tyrosine protein kinase receptor SEK; Tyrosine protein kinase TYRO1; Tyrosine protein kinase TYRO4; Tyrosine-protein kinase receptor ECK; Tyrosine-protein kinase receptor ETK1.

    浓    度  1mg/1ml
    规 格  0.1ml/100μg
    抗体来源  Rabbit
    克隆类型  polyclonal
    交叉反应  Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
    产品类型  一抗  磷酸化抗体
    研究领域  心血管 细胞生物 神经生物学 信号转导 激酶和磷酸酶 细胞膜受体
    蛋白分子量  predicted molecular weight: 105kDa
    性    状  Lyophilized or Liquid
    免 疫 原  KLH conjugated synthesised phosphopeptide derived from human Eph receptor A2 around the phosphorylation site of Tyr588 + Tyr596
    亚    型  IgG
    纯化方法  affinity purified by Protein A
    储 存 液  Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
    产品应用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500
    (石蜡切片需做抗原修复)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    产品介绍 Eph receptor A2 is the receptor for members of the ephrin-A family. It binds to ephrin-A1, -A3, -A4 and -A5. Eph receptor A3 is also a receptor for members of the ephrin-A family. It binds to ephrin-A2, -A3, -A4 and -A5 and is thought to play a role in lymphoid function. Eph receptor A4 is a receptor for members of the ephrin-A family. It binds to ephrin-A1, -A4 and -A5. It binds more poorly to ephrin-A2 and -A3. It may play a role in a signal transduction process involved in hindbrain pattern formation.
    Function : Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.
    Subunit : Homodimer. Interacts with SLA. Interacts (phosphorylated form) with VAV2, VAV3 and PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3); critical for the EFNA1-induced activation of RAC1 which stimulates cell migration. Interacts with ANKS1A. Interacts with INPPL1; regulates activated EPHA2 endocytosis and degradation. Interacts (inactivated form) with PTK2/FAK1 and interacts (EFNA1 ligand-activated form) with PTPN11; regulates integrin-mediated adhesion. Interacts with ARHGEF16, DOCK4 and ELMO2; mediates ligand-independent activation of RAC1 which stimulates cell migration. Interacts with CLDN4; phosphorylates CLDN4 and may regulate tight junctions. Interacts with ACP1.
    Subcellular Location : Cell membrane; Single-pass type I membrane protein. Cell projection, ruffle membrane; Single-pass type I membrane protein. Cell projection, lamellipodium membrane; Single-pass type I membrane protein. Cell junction, focal adhesion. Note=Present at regions of cell-cell contacts but also at the leading edge of migrating cells.
    Tissue Specificity : Expressed in brain and glioma tissue and glioma cell lines (at protein level). Expressed most highly in tissues that contain a high proportion of epithelial cells, e.g., skin, intestine, lung, and ovary.
    Post-translational modifications : Autophosphorylates. Phosphorylated on tyrosine upon binding and activation by EFNA1. Phosphorylated residues Tyr-588 and Tyr-594 are required for binding VAV2 and VAV3 while phosphorylated residues Tyr-735 and Tyr-930 are required for binding PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3). These phosphorylated residues are critical for recruitment of VAV2 and VAV3 and PI3-kinase p85 subunit which transduce downstream signaling to activate RAC1 GTPase and cell migration. Phosphorylated at Ser-897 by PKB; serum-induced phosphorylation which targets EPHA2 to the cell leading edge and stimulates cell migration. Phosphorylation by PKB is inhibited by EFNA1-activated EPHA2 which regulates PKB activity via a reciprocal regulatory loop. Dephosphorylated by ACP1.
    Ubiquitinated by CHIP/STUB1. Ubiquitination is regulated by the HSP90 chaperone and regulates the receptor stability and activity through proteasomal degradation. ANKS1A prevents ubiquitination and degradation.
    DISEASE : Genetic variations in EPHA2 are the cause of susceptibility to cataract cortical age-related type 2 (ARCC2) [MIM:613020]. A developmental punctate opacity common in the cortex and present in most lenses. The cataract is white or cerulean, increases in number with age, but rarely affects vision.
    Defects in EPHA2 are the cause of cataract posterior polar type 1 (CTPP1) [MIM:116600]. A subcapsular opacity, usually disk-shaped, located at the back of the lens. It can have a marked effect on visual acuity.
    产品细节图片2
    实验原理 :
    (1)特异性结合抗原:抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞,通常需要补体或吞噬细胞等共同发挥效应以清除病原微生物或导致病理损伤。然而,抗体可通过与病毒或毒素的特异性结合,直接发挥中和病毒的作用。
    (2)活补体:IgM、IgG1、IgG2和IgG3可通过经典途径激活补体,凝聚的IgA、IgG4和IgE可通过替代途径激活补体。
    (3)结合细胞:不同类别的免疫球蛋白,可结合不同种的细胞,参与免疫应答。
    (4)可通过胎盘及粘膜:免疫球蛋白G(IgG)能通过胎盘进入胎儿血流中,使胎儿形成自然被动
    免疫。免疫球蛋白A(IgA)可通过消化道及呼吸道粘膜,是粘膜局部抗感染免疫的主要因素。
    (5)具有抗原性:抗体分子是一种蛋白质,也具有刺机体产生免疫应答的性能。不同的免疫球蛋白分子,各具有不同的抗原性。
    (6)抗体对理化因子的抵抗力与一般球蛋白相同:不耐热,60~70℃即被破坏。各种酶及能使蛋白质凝固变性的物质,均能破坏抗体的作用。抗体可被中性盐类沉淀。在上常可用硫酸铵或硫酸钠从免疫血清中沉淀出含有抗体的球蛋白,再经透析法将其纯化。

    抗体制备过程:
    1.材料与试剂
      a.提取的动物 Ig
      b.弗氏完全佐剂和弗氏不完全佐剂
      c.青霉素和链霉素
      d.实验动物 兔
      e.其它材料及试剂
    2、选择实验活体。
    3、进行动物免疫实验。
    4、试取血样进行测试,查看免疫效果。
    5、如果免疫成功,杀死实验活体,采集全部血清。
    6、纯化出抗体。
    7、鉴定抗体。胎牛血清(无菌采制)

    我司提供以下技术外包服务:
    1. Anti-phospho-Eph receptor A2+A3+A4 (Tyr588 + Tyr596)抗体分子生物学:质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等
    2.蛋白工程:原核、哺乳动物蛋白表达系统等
    3.病毒包装:腺病毒、慢病毒等
    4.抗体工程:磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
    5.细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

    抗体的鉴定:
    1)抗体的效价鉴定:鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。
    2)抗体的特异性鉴定:抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。
    3)真核翻译起始因子2C2抗体的亲和力:是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。

    Anti-phospho-CaMK2a (pThr286)/FITC 荧光素标记抗0酸化钙/钙调素依赖蛋白激酶2α抗体IgGMulti-class antibodies规格: 0.2ml
    Rabbit Anti-Guinea IgG/Gold 金标记兔抗豚鼠IgG (10nm/15nm)Multi-class antibodies规格: 0.5ml
    成纤维细胞生长因子受体4抗体 Anti-FGFR4 0.1ml
    Goat Anti-Mouse IgG/PE-CY5 PE-CY5标记的羊抗小鼠IgG 0.1ml
    phospho-Fos B (Ser27) 英文名称: 0酸化癌基因FOS蛋白B抗体 0.1ml
    Rhesus antibody Rh phospho-STAT6(Tyr641) 0酸化信号转导和转录激活因子6抗体 规格 0.1ml
    Rabbit Anti-Guinea IgG/Gold 金标记兔抗豚鼠IgG (10nm/15nm)Multi-class antibodies规格: 0.5ml
    Integrin AlphaE2/CD103 整合素αE2抗原Multi-class antibodies规格: 0.2ml
    Anti-ADM/AM 肾上腺髓质素抗体Multi-class antibodies规格: 0.1ml
    Rhesus antibody Rh Phospho-cdc2 (Tyr15) 0酸化周期素依赖激酶2抗体 规格 0.1ml
    X-GAL染色试剂盒 50ml Sigma原料
    VDAC3 英文名称: 线粒体外膜孔蛋白3抗体(电压依赖阴离子通道蛋白3) 0.2ml
    Drosha 英文名称: 核糖核酸酶3/Drosha抗体 0.2ml
    Anti-ADM/AM 肾上腺髓质素抗体Multi-class antibodies规格: 0.1ml
    STIP1 英文名称: 应激诱导0蛋白1抗体 0.2ml
    Endomucin 英文名称: 内皮粘蛋白EMCN抗体 0.2ml
    肺癌阻抑基因1抗体 Anti-TSLC1 0.2ml
    Anti-TRH/FITC 荧光素标记促甲状腺素释放激素抗体IgGMulti-class antibodies规格: 0.2ml
    Rhesus antibody Rh Phospho-IRAK1 (Thr387) 0酸化白介素-1受体相关激酶1抗体 规格 0.1ml
    CA15-3 peptide 癌相关抗原抗原Multi-class antibodies规格: 0.5mg
    小鼠CD4分子(CD4)ELISA试剂盒 ,英文名: CD4 ELISA Kit
    大鼠单核细胞趋化蛋白4(MCP-4/CCL13)ELISA检测试剂盒Ratmonocytechemotacticprotein4,MCP-4ELISAkit 96T/48T
    人COLL2-1NO2 免疫试剂盒 Human COLL2-1NO2 ELISA kit
    英文名称MouseIP-10ELISAKit小鼠干扰素诱导蛋白10(IP-10)规格:96T/48T
    冰冻切片免疫组织化学HRP酶联DAB基础检测试剂盒(无一抗和二抗)50次
    RatAi-ypsin,ATELISA试剂盒大鼠抗胰蛋白酶(AT)ELISA试剂盒规格:96T/48T
    Anti-phospho-Eph receptor A2+A3+A4 (Tyr588 + Tyr596)抗体人促生长激素释放激素(GHRH)ELISA 试剂盒 96T/48T 试剂盒 组装/原装
    小鼠Ⅰ型胶原N末端肽(X)免疫试剂盒 Mouse cross linked N-telopeptide of type Ⅰ collagen,X ELISA Kit
    套膜蛋白(iNV)ELISA试剂盒 ,英文名: iNV ELISA Kit
    MouseskeletalmuscleActinin-α,smActinin-αELISA试剂盒小鼠横纹肌辅肌动蛋白α(smActinin-α)ELISA试剂盒规格:96T/48T
    ChickenLipopolysaccharides,LPSELISA试剂盒鸡脂多糖/内毒素(LPS)ELISA试剂盒规格:96T/48T
    HumanactivatedproteinC,APCELISAKit人活化蛋白C(APC)ELISA试剂盒规格:96T/48T
     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 三生三世,一场组化,一次豪赌

      h)即可。2. 修复大法——不仅仅是「煮一煮」微波炉修复:简单易行效果好,CST 推荐使用微波炉完成修复。合适的修复液:根据抗体说明书使用合适的修复液。用柠檬酸修复后,切片需浸泡在修复液中,自然冷却;而用 EDTA 修复后,切片可直接从修复缸中取出,直接进行下一步。注:使用不同的修复方式和不同生产商的抗体检测人肺癌组织中 EGFR 的表达。第一排为 CST 的 EGF Receptor (D38B1) XP® Rabbit mAb(#4267),EDTA 的修复方式明显优于柠檬酸盐及胃蛋白

    • v468. chapter 4 WNT 细胞通路 检测细胞GSK3活性与表达水平

      . Immunoblot using antibodies to phospho-Tyr279/216 can assess alterations in activity independent ofthe N-terminal phosphorylation, although phosphorylation atthis site is most likely to be constitutive (14) . 3. Immunoblot using antibodies to known

    • R&D Systems 蛋白芯片技术专辑

      :ARY001)为例,介绍其原理和操作步骤。其实就相当于多个Western blot集中在一张膜上。高度特异的捕获抗体点样在NC膜上(STEP 1)。捕获抗体识别磷酸化和非磷酸化受体酪氨酸激酶(RTK)的胞外结构域,随后HRP结合的anti-Phospho-Tyrosine抗体特异检测磷酸化的RTK(STEP 2)。之后,利用化学发光检测试剂来检测蛋白,产生的信号与结合的分析物呈正比。  三、R&D Systems公司蛋白芯片产品特点介绍 1、R&D Systems公司蛋白芯片应用

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥780
    上海信裕生物科技有限公司
    2025年06月14日询价
    ¥780
    上海再康生物科技有限公司
    2025年11月20日询价
    ¥590
    上海联迈生物工程有限公司
    2025年07月07日询价
    ¥1580
    上海康朗生物科技有限公司
    2026年01月28日询价
    ¥2400
    深圳市豪地华拓生物科技有限公司
    2025年07月05日询价
    Anti-phospho-Eph receptor A2+A3+A4 (Tyr588 + Tyr596)抗体
    询价